US-based cancer therapeutics developer Xcovery has initiated its Phase 2 clinical trial of ensartinib (X-396), the company's lead anaplastic
lymphoma kinase drug candidate, in patients with advanced malignant melanoma harboring alterations in ALK, including ALKATI, the company said.
Roche announced today that the European Unions (EU) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Alecensa (alectinib) as a monotherapy for the first-line treatment of adult patients with anaplastic
lymphoma kinase (ALK)-positive, advanced non-small cell lung cancer (NSCLC).
One of the peripheral smears showed atypical plasma cells along with bizarre and multinucleated cells in the bone marrow aspirate and was diagnosed as anaplastic
myeloma (Figure 1].
The European Commission has approved Switzerland-based Novartis' Zykadi to serve as first-line treatment for patients with advanced non-small cell lung cancer whose tumours are anaplastic
lymphoma kinase positive, it was reported on Friday.
Global Markets Direct's, 'Anaplastic
Oligoastrocytoma - Pipeline Review, H1 2016', provides an overview of the Anaplastic
Oligoastrocytoma pipeline landscape.
thyroid cancer (ATC) is a disease of middle-aged women.
Objective: To demonstrate use of nasotracheal intubation in airway management of large anaplastic
USPRwire, Fri Jan 29 2016] Global Markets Direct's, 'Anaplastic
Astrocytoma - Pipeline Review, H2 2015', provides an overview of the Anaplastic
Astrocytoma's therapeutic pipeline.
large cell lymphoma (ALCL) is a rare type of Non-Hodgkin lymphoma.
Based on our review of the literature, we present the second reported case of anaplastic
lymphoma kinase-positive anaplastic
large-cell lymphoma presenting in an adult with an obstructing adenoid/nasopharyngeal mass and lymphadenopathy.
large cell lymphoma (ALCL) is a peripheral T-cell lymphoma typically characterized by large lymphoid cells with abundant cytoplasm and pleomorphic, often horseshoe-shaped nuclei, exhibiting strong, uniform expression of CD30.
Brave Ulrika Dandekar, 21, was given the devastating news she had a rare type of blood cancer, called Anaplastic
Lymphoma, just three months ago.